The Impact
By improving how new therapies are developed and tested, MicroTex aims to enable more predictive, efficient, and biologically relevant approaches to therapeutic development.
1. Faster and more efficient drug development
By improving early preclinical testing, MicroTex approaches aim to reduce late-stage failure and streamline the development pipeline.
2. Improved reliability of preclinical testing
Current preclinical models do not always predict human responses accurately. Microscale approaches aim to improve this translation.
Better outcomes for patients
More predictive systems ultimately support safer and more effective therapies reaching patients.
Advancing interdisciplinary innovation
This interdisciplinary approach in MicroTex supports faster and more reliable translation of research into clinical applications.